Tim Casey

Very Low Calorie Diet before Laparoscopic Cholecystectomy
07/22/2014
Obese patients on a low calorie diet prior to undergoing a laparoscopic cholecystectomy procedure had a decrease in body weight and operation time.
Obese patients on a low calorie diet prior to undergoing a laparoscopic cholecystectomy procedure had a decrease in body weight and operation time.
Obese patients on a low calorie...
07/22/2014
First Report Managed Care
Dabigatran to Treat Patients with Acute Venous Thromboembolism
02/19/2014
New Orleans—A prespecified subgroup analysis of 2 randomized, phase 3 trials that included patients with acute venous thromboembolism (VTE) found that there was no difference in recurrent VTE or VTE-related mortality if they received...
New Orleans—A prespecified subgroup analysis of 2 randomized, phase 3 trials that included patients with acute venous thromboembolism (VTE) found that there was no difference in recurrent VTE or VTE-related mortality if they received...
New Orleans—A prespecified...
02/19/2014
First Report Managed Care
Phase 3 Trial of Cariprazine for Schizophrenia
09/19/2013
San Francisco—After 9 weeks of treatment, patients with schizophrenia who received 3 mg or 6 mg of cariprazine had significant improvements in Positive and Negative Syndrome Scale (PANSS) total score and Clinical Global Impressions-Severity...
San Francisco—After 9 weeks of treatment, patients with schizophrenia who received 3 mg or 6 mg of cariprazine had significant improvements in Positive and Negative Syndrome Scale (PANSS) total score and Clinical Global Impressions-Severity...
San Francisco—After 9 weeks of...
09/19/2013
First Report Managed Care
News
Multiple Sclerosis Treatment Options
05/17/2013
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs to treat multiple sclerosis, healthcare professionals are attempting to understand the costs, benefits, and risks associated with the various treatment options.
As the FDA approves more drugs...
05/17/2013
First Report Managed Care
Lenalidomide for Mantle Cell Lymphoma
01/22/2013
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle cell lymphoma who took lenalidomide had a 35% overall response rate to the drug and median progression-free survival of 8.8 months, according to a subset analysis of a phase 2, single-arm, open-label,...
Atlanta—Patients with mantle...
01/22/2013
First Report Managed Care
Choosing Wisely® Campaign Examines Unnecessary Tests and Procedures
10/22/2012
In a fee-for-service payment system, physicians are compensated for each test and procedure, creating an environment in which they are incentivized for the volume of care they provide. This situation has led to frustration for both patients...
In a fee-for-service payment system, physicians are compensated for each test and procedure, creating an environment in which they are incentivized for the volume of care they provide. This situation has led to frustration for both patients...
In a fee-for-service payment...
10/22/2012
First Report Managed Care
Medical Homes as Centerpiece of Healthcare Reform
06/19/2012
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other...
Orlando—In nearly 5 decades as a...
06/19/2012
First Report Managed Care
News
First-Year Cost of Administering and Monitoring Therapies for Multiple Sclerosis
01/25/2012
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an interactive tool developed to estimate the first-year cost of administering and monitoring multiple sclerosis (MS) therapies, glatiramer acetate was the cheapest treatment option, followed by interferon beta-1a...
Madrid—According to an...
01/25/2012
First Report Managed Care
Counterfeit Medications Gaining Attention
10/14/2011
Although the accurate number and dollar value of counterfeit drugs are difficult to quantify, the issue has received attention recently in the United States because pharmaceutical companies are becoming more internationally based and because...
Although the accurate number and dollar value of counterfeit drugs are difficult to quantify, the issue has received attention recently in the United States because pharmaceutical companies are becoming more internationally based and because...
Although the accurate number and...
10/14/2011
First Report Managed Care
Phase 3 Trial of Pixantrone in Treating Non-Hodgkin Lymphoma Patients
01/17/2011
Olrando—Compared with other chemotherapy agents, pixantrone proved more effective in treating patients with relapsed/refractory non-Hodgkin lymphoma (NHL), according to a randomized, controlled, international, multicenter, open-label, phase 3...
Olrando—Compared with other chemotherapy agents, pixantrone proved more effective in treating patients with relapsed/refractory non-Hodgkin lymphoma (NHL), according to a randomized, controlled, international, multicenter, open-label, phase 3...
Olrando—Compared with other...
01/17/2011
First Report Managed Care

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use